Dynamics of the Cag-type IV secretion system of Helicobacter pylori as studied by bacterial co-infections
Luisa F Jiménez-Soto1, Sabine Clausen, Annika Sprenger
1Max von Pettenkofer-Institute for Hygiene and Medical Microbiology, Ludwig-Maximilians-University, Pettenkoferstraße 9a, D-80336, Munich, Germany.
Abstract:
Many pathogenic Gram-negative bacteria possess type IV secretion systems (T4SS) to inject effector proteins directly into host cells to modulate cellular processes to their benefit. The human bacterial pathogen Helicobacter pylori, a major aetiological agent in the development of chronic gastritis, duodenal ulcer and gastric carcinoma, harbours the cag-T4SS to inject the cytotoxin associated Antigen (CagA) into gastric epithelial cells. This results in deregulation of major signalling cascades, actin-cytoskeletal rearrangements and eventually gastric cancer. We show here that a pre-infection with live H. pylori has a dose-dependent negative effect on the CagA translocation efficiency of a later infecting strain. This effect of the 'first' strain was independent of any of its T4SS, the vacuolating cytotoxin (VacA) or flagella. Other bacterial pathogens, e.g. pathogenic Escherichia coli, Campylobacter jejuni, Staphylococcus aureus, or commensal bacteria, such as lactobacilli, were unable to interfere with H. pylori's CagA translocation capacity in the same way. This interference was independent of the β1 integrin receptor availability for H. pylori, but certain H. pylori outer membrane proteins, such as HopI, HopQ or AlpAB, were essential for the effect. We suggest that the specific interference mechanism induced by H. pylori represents a cellular response to restrict and control CagA translocation into a host cell to control the cellular damage.
Insights
Previous Helicobacter pylori infection dose-dependently reduces CagA translocation by later strains. This interference by H. pylori is specific and mediated by outer membrane proteins, not other virulence factors.
Area of Science:
- Microbiology
- Cell Biology
- Pathogenesis
Background:
- Pathogenic Gram-negative bacteria use type IV secretion systems (T4SS) to inject effector proteins into host cells.
- Helicobacter pylori utilizes the cag-T4SS to inject CagA into gastric epithelial cells, leading to signaling deregulation and gastric cancer.
- CagA injection disrupts host cell functions, contributing to diseases like gastritis, ulcers, and cancer.
Purpose of the Study:
- To investigate the effect of prior H. pylori infection on the CagA translocation efficiency of subsequent infections.
- To elucidate the mechanisms and bacterial factors involved in this interference phenomenon.
- To understand how H. pylori modulates host cell interactions to control effector delivery.
Main Methods:
- Infection experiments using live H. pylori strains with varying pre-infection conditions.
- Assessment of CagA translocation efficiency using quantitative assays.
- Analysis of the role of T4SS, VacA, flagella, and specific outer membrane proteins (HopI, HopQ, AlpAB).
- Testing interference by other bacterial species (E. coli, C. jejuni, S. aureus, lactobacilli).
- Evaluation of β1 integrin receptor involvement.
Main Results:
- Pre-infection with live H. pylori significantly and dose-dependently reduced CagA translocation by a subsequent infecting strain.
- This interference was specific to H. pylori and not observed with other tested bacterial pathogens or commensals.
- The effect was independent of H. pylori's T4SS, VacA, flagella, and β1 integrin receptor availability.
- Specific outer membrane proteins, including HopI, HopQ, and AlpAB, were essential for mediating this interference.
- The mechanism appears to be a host cell response controlled by H. pylori to limit CagA delivery.
Conclusions:
- H. pylori establishes a specific interference mechanism that restricts CagA translocation by subsequent infections.
- This self-regulation by H. pylori may serve to control host cell damage and modulate the host-pathogen interaction.
- Outer membrane proteins play a crucial role in this novel interference pathway, distinct from known virulence factors.
Related Concept Videos
Gastritis II: Pathophysiology
Peptic Ulcer Disease II: Pathophysiology
Intracellular Movement of Viruses and Bacteria
Gram-negative Bacterial Protein Secretion Systems
Treating Helicobacter pylori in Peptic Ulcers: Antimicrobial Therapy
Regulation of Bacterial Virulence

